Boston Scientific is recommended as a buy with a $109 target price, implying 14% upside, driven by robust demand and niche leadership. BSX outpaces market growth through focused M&A, strong execution ...
MARLBOROUGH, Mass., Jan. 2, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 44 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 th, 2026, in ...
Boston Scientific’s BSX Cardiovascular segment operates in a $50 billion market, projected to grow nearly 9% over the 2026-2028 long-range plan (LRP). Management expects the business to outpace ...
GlobalData on MSN
Boston Scientific buys Tivus system developer SoniVie in $540m deal
Boston Scientific is acquiring SoniVie, the developer of the catheter-based Tivus intravascular ultrasound system. With a ...
Evercore ISI lowered the firm’s price target on Boston Scientific (BSX) to $112 from $113 and keeps an Outperform rating on the shares. Recovering end markets and sector rotation have “set the stage ...
Another month, and another annoying carriage dispute threatens to block sports fans from watching a game (or games) on a provider they’re paying for. At jeopardy this time is Sunday’s Patriots-Jets ...
In the early 1960s, Mack Fulwyler joined the lab of Marvin Van Dilla at the Los Alamos National Laboratory as an engineer to study the effect of fallout radiation from nuclear weapons testing on ...
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular ...
Foundational Concepts in Programming Industrial Robots. Before you can get a robot to do anything useful, you need to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results